Maharashtra Food and Drug Administration (FDA) has directed all 306 blood banks in the state to submit applications of renewal of licenses by 31st December 2016 to carry out timely inspections and approvals. There are around 53 blood banks in the state for which renewals are pending.

As stated in Drugs and Cosmetics Rules, 1945 blood bank licenses are valid for 5 years. Central Licensing Approving Authority of Central Drugs Standard Control Organization (CDSCO) renews licences after the state FDA satisfies and recommends the same for renewal for further approval from the DCGI.

FDA senior official said “All the blood banks for which licenses are about to expire on 31st December 2016 have been directed to submit the license renewal applications to avoid delays in approvals and cancellations. The applications with FDA recommendations have to be submitted to the DCGl India for further approval,”

A committee comprising CDSCO -drugs inspector, FDA -drugs inspector and an expert in the field, conducts a joint inspection and sees whether the management or organization has provided all the facilities or not. The inspection must be done within 6 months after the expiry date of the licence as per the norms.

Licences are valid for 5 years, it is important that joint inspections to be carried out by FDA and CDSCO help eliminate errors. This inspections rule out the errors on the part of the blood banks such as shortage of doctors or unavailability of kits to test antibodies or other equipment related issues. In the absence of inspections the blood banks will continue to function with loopholes.

Schedule ‘F’, Part XII-B and/or XII-C of Drugs & Cosmetics Act, 1940 requires that the blood banks shall provide adequate space, plant and equipment for any or all the operations of blood collection or blood processing. It also mandates to maintain adequate technical staff as specified in the law.

Maharashtra Food and Drug Administration (FDA) has conducted inspections on 15 civic run blood banks in the past 3 months in Mumbai. Based on the inspections, it suspended licenses of 4 municipal blood banks and canceled license of one of them. There are around 60 blood banks in the city.

PHARMABIZ

Other News

Additional Steps Announced by FDA to Modernize Clinical Trials

The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]

Read More

Accreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA 

This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]

Read More

BSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing

BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]

Read More

TUV SUD Inspects IVD Medical Devices’ Cyber Security

The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]

Read More

TGA Supports MHRA’s New Regulations

The TGA made a commitment to support the MHRA‘s new Regulations worldwide recognition framework for pharmaceuticals. Following the UK’s exit from the European Union, a new international recognition framework for medicines has been developed specifically […]

Read More

Medical Devices with Extended CE Certification Are Now Accepted On The UK Market

The MHRA revised its guidelines to make clear its stance and reflect its intention to extend the acceptance of CE-marked medical devices on the British market beyond June 30th, 2023. A statutory document that will […]

Read More

The NMPA Enhanced Regulation of Cosmetic Medicine

According to a representative of the State Administration for Market Regulation, after the industry’s quick development, prominent issues like unethical medical practices, fake goods, false advertising, and price fraud emerged, endangering the health and interests […]

Read More

Radiation Sterilization Master File Pilot Program Announced by CDRH

CDRH is establishing a Radiation Sterilization Master File Pilot Program to assist businesses in developing less troublesome regulatory methods for sterilizing licensed medical equipment, such as switching radiation sources. The pilot program, which is optional, […]

Read More